Free Trial

Cardinal Health (CAH) Competitors

Cardinal Health logo
$148.64 +0.27 (+0.18%)
Closing price 09/17/2025 03:59 PM Eastern
Extended Trading
$150.00 +1.36 (+0.91%)
As of 08:21 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CAH vs. DXCM, HOLX, MMSI, AMN, COR, ELV, HAE, ITGR, MCK, and HSIC

Should you be buying Cardinal Health stock or one of its competitors? The main competitors of Cardinal Health include DexCom (DXCM), Hologic (HOLX), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Cencora (COR), Elevance Health (ELV), Haemonetics (HAE), Integer (ITGR), McKesson (MCK), and Henry Schein (HSIC). These companies are all part of the "medical" sector.

Cardinal Health vs. Its Competitors

Cardinal Health (NYSE:CAH) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk.

DexCom has a net margin of 13.29% compared to Cardinal Health's net margin of 0.70%. DexCom's return on equity of 30.41% beat Cardinal Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Cardinal Health0.70% -74.45% 4.14%
DexCom 13.29%30.41%10.08%

Cardinal Health has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500.

Cardinal Health currently has a consensus target price of $165.93, indicating a potential upside of 11.63%. DexCom has a consensus target price of $99.89, indicating a potential upside of 30.68%. Given DexCom's stronger consensus rating and higher possible upside, analysts clearly believe DexCom is more favorable than Cardinal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cardinal Health
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.79
DexCom
0 Sell rating(s)
5 Hold rating(s)
14 Buy rating(s)
3 Strong Buy rating(s)
2.91

In the previous week, DexCom had 9 more articles in the media than Cardinal Health. MarketBeat recorded 31 mentions for DexCom and 22 mentions for Cardinal Health. Cardinal Health's average media sentiment score of 1.51 beat DexCom's score of 1.12 indicating that Cardinal Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cardinal Health
21 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
DexCom
22 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

87.2% of Cardinal Health shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 0.1% of Cardinal Health shares are owned by company insiders. Comparatively, 0.3% of DexCom shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Cardinal Health has higher revenue and earnings than DexCom. Cardinal Health is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardinal Health$222.58B0.16$1.56B$6.4523.05
DexCom$4.30B6.97$576.20M$1.4453.08

Summary

DexCom beats Cardinal Health on 13 of the 17 factors compared between the two stocks.

Get Cardinal Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CAH vs. The Competition

MetricCardinal HealthMED/DENTAL IndustryMedical SectorNYSE Exchange
Market Cap$35.43B$16.91B$5.74B$21.52B
Dividend Yield1.36%1.58%5.86%3.50%
P/E Ratio23.0516.9076.8729.81
Price / Sales0.162.28448.2552.31
Price / Cash12.7212.8337.2224.68
Price / Book-13.463.3113.844.54
Net Income$1.56B$472.94M$3.29B$999.97M
7 Day Performance-2.51%-4.74%-0.76%-0.18%
1 Month Performance-0.71%-6.78%3.83%4.37%
1 Year Performance33.43%0.95%84.84%14.40%

Cardinal Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CAH
Cardinal Health
4.9649 of 5 stars
$148.64
+0.2%
$165.93
+11.6%
+33.4%$35.43B$222.58B23.0557,700Positive News
DXCM
DexCom
4.9762 of 5 stars
$77.99
-3.1%
$99.89
+28.1%
+10.9%$30.58B$4.03B54.1610,300Positive News
HOLX
Hologic
4.7981 of 5 stars
$66.54
-0.3%
$78.00
+17.2%
-16.8%$14.80B$4.03B27.617,063Analyst Downgrade
Analyst Revision
MMSI
Merit Medical Systems
4.7673 of 5 stars
$92.25
-0.8%
$107.00
+16.0%
-16.0%$5.46B$1.36B46.837,400Positive News
AMN
AMN Healthcare Services
4.5272 of 5 stars
$20.97
+0.6%
$28.25
+34.7%
-58.7%$803.61M$2.98B-2.702,968Short Interest ↓
COR
Cencora
4.8374 of 5 stars
$297.64
+1.8%
$311.25
+4.6%
+23.1%$57.71B$293.96B30.6246,000Positive News
ELV
Elevance Health
4.9166 of 5 stars
$308.03
-1.8%
$411.06
+33.4%
-43.3%$69.36B$177.01B13.11104,200Positive News
HAE
Haemonetics
4.925 of 5 stars
$54.02
-0.7%
$85.18
+57.7%
-34.8%$2.60B$1.36B16.523,023
ITGR
Integer
3.8661 of 5 stars
$106.01
-0.9%
$140.25
+32.3%
-18.6%$3.71B$1.72B46.7011,000Positive News
MCK
McKesson
4.6181 of 5 stars
$696.53
+1.3%
$725.10
+4.1%
+34.7%$86.63B$359.05B27.7745,000Positive News
HSIC
Henry Schein
3.9777 of 5 stars
$67.74
-2.4%
$76.67
+13.2%
-5.4%$8.21B$12.67B21.8525,000Positive News
Analyst Revision

Related Companies and Tools


This page (NYSE:CAH) was last updated on 9/18/2025 by MarketBeat.com Staff
From Our Partners